ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2018 American Transplant Congress

    Liver Transplantation as a Life Saving Procedure after Post Resection Liver Failure and Iatrogenic Liver Injuries

    T. Thorsen,1 J. Solheim,1 R. Horneland,1 P-.D. Line,1 K. Labori,2 E. Aandahl.1

    1Section for Transplant Surgery, Oslo University Hospital, Oslo, Norway; 2Section for Hepatobiliary Surgery, Oslo University Hospital, Oslo, Norway.

    Introduction: Iatrogenic injuries to vital structures of the liver and liver failure post liver resection are both associated with high mortality. Selected patients that were…
  • 2018 American Transplant Congress

    A Novel Dropout Risk Score in Hepatocellular Carcinoma (HCC) Patients Listed for Liver Transplant (LT) – Identifying a Threshold That Predicts Worse Post-LT Survival in Short Wait Regions

    N. Mehta, J. Dodge, F. Yao.

    UCSF, San Francisco.

    Background: Short wait time to LT for HCC patients may result in transplanting aggressive tumors at high risk for HCC recurrence who otherwise would have…
  • 2018 American Transplant Congress

    Malignancies in Kidney Transplant Recipients: A Long-Term Observational Study

    D. Khadzhynov, F. Halleck, F. Froehlich, L. Lehner, E. Schrezenmeyer, K. Budde, O. Staeck.

    Nephrology and Internal Intensive Care, Charite Universitaetsmedizin Berlin, Berlin, Germany.

    Background: Previous studies have shown increased incidence of malignancies in patients after kidney transplantation. However, most of the existing data on post-transplant malignancies is limited…
  • 2018 American Transplant Congress

    Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients

    O. Seree, M. Altieri, J. Dumortier, GReF2.

    Réseau Régional de Cancérologie Onco-Basse Normandie, Herouville St-Clair, France; Service d'Hépato-Gastroentérologie, Nutrition et Oncologie Digestive, CHU CAEN Hôpital Côte de Nacre, Caen, France; Hospices Civils de Lyon, Lyon, France.

    Background and aims: De novo malignancies are one of the major late complications and cause of death after liver transplantation (LT). Using extensive data from…
  • 2018 American Transplant Congress

    How Evaluation for Living Kidney Donation Saved My Life

    M. Guthoff,1 T. Mühlbacher,1 S. Nadalin,2 N. Heyne.1

    1Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; 2Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.

    Purpose:In order to ensure eligibility for living kidney donation, donor candidates undergo a thorough medical evaluation. This evaluation process might reveal previously unknown medical conditions,…
  • 2018 American Transplant Congress

    Single Center Experience in Use of Check Point Inhibitors and Outcomes in Kidney Transplant Recipients

    K. Venkatachalam, R. Delos Santos, T. Alhamad.

    Transplant Nephrology, Washington University, St. Louis, MO; Transplant Nephrology, Washington University, St. Louis, MO.

    Organ transplant recipients who are on lifelong immunosuppressive agents are those who are at increased risk of malignancies (excess absolute risk of 719 cases per…
  • 2018 American Transplant Congress

    De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea

    Y. Yoon,1 J. Lee,1 Y. You,2 D. Kim.2

    1Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea; 2Surgery, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

    IntroductionDe novo malignancies are one of the leading causes of late mortality after liver transplantation (LT). We analyze the clinical characteristics, prevalence, risk factors, prevention…
  • 2018 American Transplant Congress

    Donor Derived Renal Cell Carcinoma (RCC) Transmission Events 2008-2016: A Report of the OPTN Disease Transmission Advisory Committee (DTAC)

    M. Pavlakis, M. Michaels, S. Tlusty, N. Turgeon, G. Vece, C. Wolfe, R. Wood, M. Nalesnik.

    OPTN/UNOS, RCC Work Group.

    Background: RCC is the most common renal tumor reported to the OPTN and reviewed by DTAC for assessment of potential donor transmission. Organs with concern…
  • 2018 American Transplant Congress

    Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma

    Y. Hou,1 Z. Yu,2 N. Tam,1 S. Huang,1 J. Yang,1 L. Wu,1 Y. Ma,1 X. He.1

    1Department of Organ Transplantation, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China; 2Laboratory of Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.

    Objectives Increasing evidence suggests that long non-coding RNA (lncRNA) plays a vital role in metastasis and development in hepatocellular carcinoma (HCC). Tumor progression severely affect…
  • 2017 American Transplant Congress

    BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

    R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.

    Henry Ford Transplant Institute, Detroit, MI

    BackgroundThe WHO agency for cancer research has classified BKV as "possibly carcinogenic".The etiological role of BKV in human cancer, however,remains controversial.We present 5 cases of…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences